SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > April 2017

« Previous month Next month »

Daiichi Sankyo pumping $135m into antibody-drug conjugate production

28-Apr-2017 - Daiichi Sankyo will plough ‎¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.

DISPATCHES FROM BPI EUROPE 2017

CHO stopper? Biogen looks to alternative cell lines for future of bioproduction

28-Apr-2017 - The Chinese hamster ovary (CHO) cell line is not the future for biomanufacturing says Biogen, which will publish results from a study of alternative hosts later this year.

GSK to ship malaria vaccine for African pilot programme

28-Apr-2017 - GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme. 

PharmaCell to make autologous cell therapies for Lion Biotech

28-Apr-2017 - Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.

DISPATCHES FROM BPI EUROPE 2017

Boehringer Ingelheim upping capacity with €700m mammalian cell culture plant

27-Apr-2017 - Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.

United BioPharma selects GE Healthcare’s FlexFactory for Taiwan HIV drug plant

27-Apr-2017 - United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.

Thermo Fisher collaborates to establish single-use and automation site in China

27-Apr-2017 - Mab-Venture Biopharma has entered a collaboration to establish an antibody development and production plant in China incorporating Thermo Fisher’s single-use bioreactors and SmartFactory automated technology.

DISPATCHES FROM BPI EUROPE 2017

Messenger RNA a ‘game-changer’ for vaccine industry, Sanofi Pasteur

26-Apr-2017 - Sanofi Pasteur says heavy investment in messenger RNA (mRNA) is warranted as such technology could revolutionise vaccine development and manufacturing.

BPI Europe 2017: Biomanufacturing industry goes Dutch

25-Apr-2017 - The bioprocessing industry has donned its clogs and made its way to Amsterdam. And Biopharma-Reporter is here too, bringing you the best of BPI Europe 2017.

update

US FDA warns Lonza about Walkersville site

25-Apr-2017 - The US FDA has warned Lonza about operations at its facility in Walkersville, Maryland, raising concerns about validation and aseptic process simulations.

Fresenius Kabi to buy Merck KGaA biosimilar candidates

25-Apr-2017 - Fresenius Kabi has announced plans to purchase Merck KGaA’s biosimilars business. 

DISPATCHES FROM BPI EUROPE 2017

Getting a feel for biomanufacturing at the Biotech Training Facility

25-Apr-2017 - Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.

Filtration is a ‘high value process at a marginal cost,’ says Danaher

25-Apr-2017 - Danaher reported mid-single-digit growth from its bioprocessing subsidiary Pall Life Science and expects a continued trajectory to support Biopharma’s filtration needs.

Samsung Bioepis to take on J&J with FDA approved Remicade biosimilar

24-Apr-2017 - Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.

UK MHRA announces pre-election quiet period

21-Apr-2017 - Tory Prime Minister Teresa May’s decision to call a snap general election to stymie political opposition of her stewardship of the UK’s withdrawal from the European Union will see the...

A cracking new method: Valneva and Bavarian Nordic’s hen egg alternative

21-Apr-2017 - European biotech companies Valneva and Bavarian Nordic have entered a commercial agreement to develop cell-based vaccines using production methods that are faster and cheaper than methods that use hen’s eggs. ...

BioInvent buys Merck single-use tech to up mAb capacity

21-Apr-2017 - BioInvent International AB has acquired a range of different single-use bioreactors from Germany’s Merck to up monoclonal antibody (mAb) capacity at its plant in Lund, Sweden.

Sartorius Stedim Biotech announces French government-backed R&D project

21-Apr-2017 - Sartorius Stedim Biotech (SSB) has announced a €23m ($24.6m) research and development (R & D) programme with funding from local government bodies La Region Provence-Alpes-Cote d’Azur and la Metropole Aix-Marseille...

Wearable drug delivery tech firm Unilife files for Chapter 11 bankruptcy

20-Apr-2017 - Unilife Corporation has filed for Chapter 11 bankruptcy and confirmed that a key customer for its wearable injectors business has halted a project.

Infographic

Hey big vendor... Is bioprocessing consolidation good for the end-user?

19-Apr-2017 - Price hikes and lack of innovation, or better buying power and end-to-end services? Experts are split on supplier M&A and its effect on biomanufacturers.

News in brief

Synpromics announces £5.2M British investment in gene therapy tech

19-Apr-2017 - Scottish synthetic biology firm Synpromics has received £5.2M ($6.6M) to enhance its synthetic promoter design technology used in gene therapy development.

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

19-Apr-2017 - Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Cobra to boost gene therapy and CAR-T capacity through £15m investment

18-Apr-2017 - Cobra Biologics has said it will spend £15m ($19m) to increase gene therapy production capacity, citing customer demand and market opportunities.

DHL looks to strengthen presence in South American market

18-Apr-2017 - Deutsche Post DHL Group’s contract logistics business, DHL Supply Chain, has announced its intention to acquire Brazilian transport service provider Polar Transportes. 

Fujifilm invests $130m in CDMO business, ups mammlian bioreactor capacity 70%

18-Apr-2017 - Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...